MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1016/j.bmcl.2022.128904

Медицинская библиотека · Bioorganic & medicinal chemistry letters · 2022

Discovery and antiviral profile of new sulfamoylbenzamide derivatives as HBV capsid assembly modulators.

Ivanova Bencheva Leda, Donnici Lorena, Ferrante Luca, Prandi Adolfo, Sinisi Roberta, De Matteo Marilenia, Randazzo Pietro, Conti Matteo, Di Lucia Pietro, Bono Elisa, Giustini Leonardo, Vittoria Orsale Maria, Patsilinakos Alexandros, Monteagudo Edith, Iannacone Matteo, Summa Vincenzo, Guidotti Luca G, De Francesco Raffaele, Di Fabio Romano

СтатьяПоддержка исследования: вне правительства СШАПеревод в очереди

Аннотация

Chronic hepatitis B (CHB) is a major worldwide public health problem and novel anti-HBV therapies preventing liver disease progression to cirrhosis and hepatocellular carcinoma are urgently needed. Over the last several years, capsid assembly modulators (CAM) have emerged as clinically effective anti-HBV agents which can inhibit HBV replication in CHB patients. As part of a drug discovery program aimed at obtaining novel CAM endowed with high in vitro and in vivo antiviral activity, we identified a novel series of sulfamoylbenzamide (SBA) derivatives. Compound 10, one of the most in vitro potent SBA-derived CAM discovered to date, showed excellent pharmacokinetics in mice suitable for oral dosing. When studied in a transgenic mouse model of hepatic HBV replication, it was considerably more potent than NVR 3-778, the first sulfamoylbenzamide (SBA) CAM that entered clinical trials for CHB, at reducing viral replication in a dose-dependent fashion. We present herein the discovery process, the SAR analysis and the pre-clinical profile of this novel SBA CAM.

Для цитирования: Ivanova Bencheva Leda, Donnici Lorena, Ferrante Luca, Prandi Adolfo, Sinisi Roberta, De Matteo Marilenia, Randazzo Pietro, Conti Matteo, Di Lucia Pietro, Bono Elisa, Giustini Leonardo, Vittoria Orsale Maria, Patsilinakos Alexandros, Monteagudo Edith, Iannacone Matteo, Summa Vincenzo, Guidotti Luca G, De Francesco Raffaele, Di Fabio Romano. Discovery and antiviral profile of new sulfamoylbenzamide derivatives as HBV capsid assembly modulators.. Bioorganic & medicinal chemistry letters. 2022. DOI: 10.1016/j.bmcl.2022.128904.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.